Orin Green Financial, LLC Protalix Bio Therapeutics, Inc. Transaction History
Orin Green Financial, LLC
- $248 Million
- Q3 2025
A detailed history of Orin Green Financial, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Orin Green Financial, LLC holds 61,200 shares of PLX stock, worth $113,832. This represents 0.05% of its overall portfolio holdings.
Number of Shares
61,200
Previous 61,200
-0.0%
Holding current value
$113,832
Previous $90,000
51.11%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding PLX
# of Institutions
82Shares Held
10.6MCall Options Held
23.6KPut Options Held
95.4K-
Opaleye Management Inc. Boston, MA2.58MShares$4.8 Million0.96% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.32MShares$2.45 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL902KShares$1.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.52 Million0.0% of portfolio
-
Stratos Wealth Partners, Ltd.500KShares$930,0000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $92.5M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...